U.S. Menopause Market Size & Outlook, 2022-2030
U.S. menopause market, 2018-2030 (US$M)
Related Markets
U.S. menopause market highlights
- The U.S. menopause market generated a revenue of USD 5,120.4 million in 2022 and is expected to reach USD 7,368.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.7% from 2023 to 2030.
- In terms of segment, dietary supplements was the largest revenue generating treatment in 2022.
- Dietary Supplements is the most lucrative treatment segment registering the fastest growth during the forecast period.
Menopause market data book summary
| Market revenue in 2022 | USD 5,120.4 million |
| Market revenue in 2030 | USD 7,368.7 million |
| Growth rate | 4.7% (CAGR from 2022 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Dietary Supplements |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | OTC pharma products, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.7% of the global menopause market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. menopause market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 7,368.7 million by 2030.
Dietary supplements was the largest segment with a revenue share of 94.09% in 2022. Horizon Databook has segmented the U.S. menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
As the millennial population is aging, the country has a large number of women entering menopause; around 6,000 women are expected to enter menopause each day in the U.S. According to a menopause survey conducted by AARP, a U.S.-based nonprofit organization, for its female members between the ages 60 and 69. Around 72% of women revealed that menopausal symptoms affected their lives and 8% of them admitted that the effects were extreme.
Key players in the region are conducting campaigns to create awareness about menopause and the role of dietary supplements in easing the transition through it. In September 2019, EQUELLE partnered with actress Kate Walsh for its campaign Live Hot, Stay Cool.
The campaign included sharing of menopauserelated experiences & tips by Kate with other women and the role that EQUELLE, a dietary supplement, played during the transition. The large number of menopausal women and initiatives undertaken to promote the use of dietary supplements during menopause are expected to contribute to the adoption of these products.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Menopause Market Scope
Menopause Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. menopause market size, by treatment, 2018-2030 (US$M)
U.S. Menopause Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
